Imagine a future where you can eat out with fewer worries

With your help we can get closer to this goal.

 

Contribute to research on a study medication for celiac disease with minimal compromises to your life - no biopsies, no injections.

The Solutions for Celiac Study

This NIH-funded clinical research study is evaluating a drink-based study medication, latiglutenase, and its ability to relieve common symptoms suffered by celiac disease patients typically experienced after accidental gluten exposure.

The Solutions for Celiac Study has been designed to be as non-intrusive on your life as possible:

  • Latiglutenase is taken as a drink with meals

  • No mandatory endoscopy with biopsy

  • No treatment injections

Plus, all participants will receive the active study medication at some point during the trial.

Celiac disease is an autoimmune disorder that damages the villi of the small intestine upon ingestion of gluten and can lead to a variety of gastrointestinal and non-gastrointestinal symptoms and effects.

Clinical trials are a crucial aspect of clinical research and involve the participation of volunteers to help find new methods of prevention, detection, and treatment of disease.

Find out more on our FAQ page.

The Solutions for Celiac Study is focused on investigating real-world symptom relief of a drink-based study medication called latiglutenase.  The study involves no mandatory endoscopy with biopsy procedures, and no treatment-based injections.

Read more on our About page.

What is Celiac Disease?

Clinical Trials

Solutions for Celiac Trial

Share information about the Solutions for Celiac Study

©2020 by ImmunogenX